000 01669 a2200493 4500
005 20250515173845.0
264 0 _c20090730
008 200907s 0 0 eng d
022 _a1558-8238
024 7 _a10.1172/JCI37977
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPatel, Naina
245 0 0 _aA dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cJul 2009
300 _a1964-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xmetabolism
650 0 4 _aAsparaginase
_xmetabolism
650 0 4 _aCathepsin B
_xphysiology
650 0 4 _aCell Line
650 0 4 _aCysteine Endopeptidases
_xphysiology
650 0 4 _aHumans
650 0 4 _aLymphocytes
_xenzymology
650 0 4 _aLysosomes
_xenzymology
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
700 1 _aKrishnan, Shekhar
700 1 _aOffman, Marc N
700 1 _aKrol, Marcin
700 1 _aMoss, Catherine X
700 1 _aLeighton, Carly
700 1 _avan Delft, Frederik W
700 1 _aHolland, Mark
700 1 _aLiu, Jizhong
700 1 _aAlexander, Seema
700 1 _aDempsey, Clare
700 1 _aAriffin, Hany
700 1 _aEssink, Monika
700 1 _aEden, Tim O B
700 1 _aWatts, Colin
700 1 _aBates, Paul A
700 1 _aSaha, Vaskar
773 0 _tThe Journal of clinical investigation
_gvol. 119
_gno. 7
_gp. 1964-73
856 4 0 _uhttps://doi.org/10.1172/JCI37977
_zAvailable from publisher's website
999 _c18932753
_d18932753